Technology >> CEO Interviews >> August 21, 2000
Sir ARNOLD TAKEMOTO is President and Chief Executive Officer of
CancerOption.com, Inc. He brings to CancerOption.com his unique and
innovative approaches to cancer therapies and immunological support. His
detailed protocols that he is currently implementing as a chemist,
biochemist and nutritionist are the basis of CancerOption's proprietary
content. Sir Arnold's personal mission statement is to provide strong
clinical support for cutting-edge complementary protocols and to
facilitate physicians in their implementation of cancer therapies.
Sir Arnold is a chief consultant to physicians and cancer clinics
worldwide. He also attends workshops at many international medical
conferences as a keynote speaker or guest lecturer and coordinates
clinical studies in adjunctive cancer programs and innovative approaches
to heart disease. Sir Arnold received his Bachelor's of Science in
Chemistry from Clarkson College of Technology in Potsdam, New York in
1966. He also compiled medical research on behalf of the University of
Vermont Medical School and Medical Center and the University of Colorado
Medical Center. Sir Arnold completed his studies at Denver University
Graduate School under the auspice of a National Science Foundation
Research Grant. Profile
TWST: Could we start with a history and background on CancerOption.com? Sir Arnold: CancerOption.com was founded in March 1998. Originally, it
was created not only as an informational site